H e r v y c t a w e b s i t e d e s i g n
A website design for Dr Reddy’s cancer drug for HER2+ breast cancer
UI/UX Director Lisa Rath | UI/UX Concept Niloy Kundu | UI/UX Development Sonal Singh | Animators Anirudha Hajare, Sonal Singh | Tech Lead Vikrant Gupta | Developer Nikita Agarwal
Dr. Reddy’s Laboratories Limited (Dr. Reddy’s) launched Hervycta, a biosimilar brand of the oncological innovation Trastuzumab, and an approved treatment option for HER2+ breast cancers.In India, as well as most countries across the globe, the promotion and advertising of prescription medicines is heavily regulated. In several countries, laws prohibit the promotion of prescription drugs directly to consumers. Dr. Reddy’s asked us to create the branding identity and design website of Hervycta within these restrictions.
read more about this project at www.icdindia.com
